Safety, pharmacokinetics and pharmacodynamics of a novel anti-asthmatic drug, XC8, in healthy probands. (PubMed, Pulm Pharmacol Ther) - Oct 10, 2019 - P1 | "XC8 was safe and well tolerated. A phase 2 study is being performed to further evaluate the potential role of XC8 in asthma treatment."
Clinical • Journal • PK/PD data • Asthma • Respiratory Diseases
|